Pathway analysis of the differentially expressed proteins between NAT- and RCC tumor-derived CD45+ cells revealed the up-regulation of cellular processes associated with metabolism, including the TCA cycle, pyruvate metabolism, and fatty acid metabolism in NAT CD45+ cells (Fig. 5, supplemental Table S4 - WebGestalt Pathway Analysis table). Here, BRD2 is linked to renal cell carcinoma.